New LED Microscope Completes Line of Clinical and Research Tools
By LabMedica International staff writers Posted on 26 Jul 2015 |
A popular microscope used for both clinical and research applications is now available with LED illumination.
The Leica (Wetzlar, Germany) DM2500 and DM2500 LED microscopes represent a class of tools for demanding tasks in life science routine and research applications. With their powerful transmitted light illumination, high-quality optical performance, and state-of-the-art accessories, the Leica DM2500 and DM2500 LED are especially well-suited for challenging life science research tasks that require differential interference contrast or high-performance fluorescence.
The difference between the two microscopes is their illumination: The Leica DM2500 LED is equipped with LED illumination for transmitted light, whereas the Leica DM2500 works with halogen. Both types of illumination render a realistic impression of the colors of the sample, so that users in clinical applications, such as the frequently used HE specimen staining, are able to assess the colors of their samples accurately. With the launch of the Leica DM2500 LED, Leica Microsystems has completed its Leica DM1000 to 3000 series of microscopes. All the models in this series are now available with LED illumination. The microscopes are certified for in vitro diagnostics (IVD) use.
The ultra-bright LED illumination of the newly released Leica DM2500 LED offers a constant color temperature at all light intensities, enabling particularly fine differentiation of colors in stained specimens. Users benefit from the brightness and color accuracy of the LED illumination in all other transmitted light contrasting techniques, such as brightfield, polarized light, and darkfield. LEDs offer the general advantages of no sample heating, low energy consumption, and long life time.
"The specially-developed LED illumination makes the Leica DM2500 LED an ideal microscope for challenging experiments requiring different contrasting techniques and for users who prefer a manual instrument," said Dr. Jasna Gilbert, product manager at Leica Microsystems. "The Leica DM2500 LED has now completed our DM1000 to 3000 series. All the models are available with either LED or halogen illumination. Besides the new illumination, the Leica DM2500 LED offers all the other benefits of the microscope series such as the unique ergonomics design for user comfort and convenience."
Related Links:
Leica
The Leica (Wetzlar, Germany) DM2500 and DM2500 LED microscopes represent a class of tools for demanding tasks in life science routine and research applications. With their powerful transmitted light illumination, high-quality optical performance, and state-of-the-art accessories, the Leica DM2500 and DM2500 LED are especially well-suited for challenging life science research tasks that require differential interference contrast or high-performance fluorescence.
The difference between the two microscopes is their illumination: The Leica DM2500 LED is equipped with LED illumination for transmitted light, whereas the Leica DM2500 works with halogen. Both types of illumination render a realistic impression of the colors of the sample, so that users in clinical applications, such as the frequently used HE specimen staining, are able to assess the colors of their samples accurately. With the launch of the Leica DM2500 LED, Leica Microsystems has completed its Leica DM1000 to 3000 series of microscopes. All the models in this series are now available with LED illumination. The microscopes are certified for in vitro diagnostics (IVD) use.
The ultra-bright LED illumination of the newly released Leica DM2500 LED offers a constant color temperature at all light intensities, enabling particularly fine differentiation of colors in stained specimens. Users benefit from the brightness and color accuracy of the LED illumination in all other transmitted light contrasting techniques, such as brightfield, polarized light, and darkfield. LEDs offer the general advantages of no sample heating, low energy consumption, and long life time.
"The specially-developed LED illumination makes the Leica DM2500 LED an ideal microscope for challenging experiments requiring different contrasting techniques and for users who prefer a manual instrument," said Dr. Jasna Gilbert, product manager at Leica Microsystems. "The Leica DM2500 LED has now completed our DM1000 to 3000 series. All the models are available with either LED or halogen illumination. Besides the new illumination, the Leica DM2500 LED offers all the other benefits of the microscope series such as the unique ergonomics design for user comfort and convenience."
Related Links:
Leica
Read the full article by registering today, it's FREE!

Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!

Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read moreMolecular Diagnostics
view channel
New Biomarker Panel to Enable Early Detection of Pancreatic Cancer
Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more
Ultrarapid Whole Genome Sequencing for Neonatal and Pediatric Patients Delivers Results In 48 Hours
Genetic diseases are the leading identifiable cause of infant mortality, and early diagnosis is crucial to improve patient outcomes. In the neonatal and pediatric intensive care units (NICU and PICU),... Read more
AI-Enabled Blood Test Demonstrates Diagnostic, Prognostic and Predictive Utility Across Cancer Continuum
Cancer remains a major challenge in healthcare due to difficulties in early detection and accurate diagnosis. Many cancers are diagnosed at advanced stages, limiting treatment options and impacting survival rates.... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer
Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more
Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes
Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read moreMicrobiology
view channel
Viral Load Tests Can Help Predict Mpox Severity
Mpox is a viral infection that causes flu-like symptoms and a characteristic rash, which evolves significantly over time and varies between patients. The disease spreads mainly through direct contact with... Read more
Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. It significantly heightens the risk of... Read morePathology
view channel
AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care
Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
AI Tool Enhances Interpretation of Tissue Samples by Pathologists
Malignant melanoma, a form of skin cancer, is diagnosed by pathologists based on tissue samples. A crucial aspect of this process is estimating the presence of tumor-infiltrating lymphocytes (TILs), immune... Read more
AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease
Senescent cells, which stop growing and reproducing due to injury, aging, or disease, play a critical role in wound repair and aging-related diseases like cancer and heart disease. These cells, however,... Read more
Novel Fluorescent Probe Shows Potential in Precision Cancer Diagnostics and Fluorescence-Guided Surgery
Hepatocellular carcinoma (HCC), a common type of liver cancer, is difficult to diagnose early and accurately due to the limitations of current diagnostic methods. Glycans, carbohydrate structures present... Read moreTechnology
view channel
Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation
Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Ultra-Sensitive Biosensor Based on Light and AI Enables Early Cancer Diagnosis
Cancer diagnosis is often delayed due to the difficulty in detecting early-stage cancer markers. In particular, the concentration of methylated DNA in the bloodstream during the early stages of cancer... Read moreIndustry
view channel
2025 COMPAMED Innovation Forum Highlights Pioneering Work in Cancer Diagnostics
Cancer cases are among the biggest challenges faced by global healthcare systems. The incidence has risen in recent decades, not least on account of demographic change and escalating risk factors.... Read more
Quanterix Completes Acquisition of Akoya Biosciences
Quanterix Corporation (Billerica, MA, USA) has completed its previously announced acquisition of Akoya Biosciences (Marlborough, MA, USA), paving the way for the creation of the first integrated solution... Read more
Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
Lunit (Seoul, South Korea) and Microsoft (Redmond, WA, USA) have entered into a collaboration to accelerate the delivery of artificial intelligence (AI)-powered healthcare solutions. In conjunction with... Read more